Bathi sadurunge bunga, pajak, lan amortisasi: therapeuticsmd.com (TXMD)

Will FDA patents and advanced logistics help TherapeuticsMD, Inc. (TXMD) strengthen its position? Changes in EBITDA indicate delisting risks and debt burden, with the current mark standing at 0.00. However, owning the rights to bioidentical agents allows the company to confidently manage pricing power within the women's hormone therapy niche.

TXMD Bathi operasional EBITDA TherapeuticsMD (23.11.2025 - 12.11.2026)

TherapeuticsMD - rincian analitis lan metrik utama (TXMD)

- kuotasi saiki lan rata-rata prakiraan nilai:

Kutipan saham TherapeuticsMD Inc|TXMD - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar TherapeuticsMD|TXMD - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham TherapeuticsMD|TXMD - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku therapeuticsmd.com|TXMD - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas TherapeuticsMD, Inc.|TXMD - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal TherapeuticsMD Inc|TXMD - Gunggung utang perusahaan|Rasio utang marang aset resik TherapeuticsMD|TXMD - Utang jangka dawa perusahaan|Utang jangka cendhak TherapeuticsMD|Rasio jangkoan perantara therapeuticsmd.com

- data bathi lan kelipatan valuasi:

TXMD - Bathi resik|Proyeksi bathi mangsa ngarep TherapeuticsMD, Inc.|TXMD - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake TherapeuticsMD Inc|TXMD - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan TherapeuticsMD|TXMD - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) TherapeuticsMD|TXMD - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan therapeuticsmd.com|TXMD - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep TherapeuticsMD, Inc.

Ringkesan analitik perusahaan:TherapeuticsMD, Inc.

For a fundamental valuation of TherapeuticsMD, Inc. (TXMD), it is essential to understand how demand for women's health medications and hormone therapy is monetized. This indicator aggregates daily cash inflows from core operations, reflecting the organization's real operational efficiency through total EBITDA; meanwhile, prolonged stabilization of these values may signal either preparation for scaling the SAM or a stagnation in current demand.

Karo sapa TherapeuticsMD, Inc. saingan

OGN - Bathi operasional sadurunge ngurangi amortisasi|DARE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi palatin.com